Bukwang Pharmaceutical Co., Ltd. (KRX:003000)
3,400.00
+60.00 (1.80%)
At close: Aug 13, 2025, 3:30 PM KST
Bukwang Pharmaceutical Market Cap
Bukwang Pharmaceutical has a market cap or net worth of 342.86 billion as of August 14, 2025. Its market cap has decreased by -7.42% in one year.
Market Cap
342.86B
Enterprise Value
290.63B
Revenue
173.50B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,400.00
Market Cap Chart
Since August 29, 1995, Bukwang Pharmaceutical's market cap has increased from 63.76B to 342.86B, an increase of 437.77%. That is a compound annual growth rate of 5.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 335.46B | 6.76% |
Dec 30, 2024 | 314.21B | -24.75% |
Dec 28, 2023 | 417.57B | -30.29% |
Dec 29, 2022 | 598.98B | -32.17% |
Dec 30, 2021 | 883.07B | -54.11% |
Dec 30, 2020 | 1,924.17B | 109.52% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.45T |
Celltrion | 38.14T |
ALTEOGEN | 22.98T |
Yuhan | 8,383.50B |
SK Biopharmaceuticals | 7,737.35B |
PharmaResearch | 7,064.96B |
Peptron | 6,989.21B |
LigaChem Biosciences | 5,419.69B |